Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients - Wikidata - wikimedia - TriplyDB

Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients

Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients

http://www.wikidata.org/entity/Q34397337

about

Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.Blood Pressure Response to Zofenopril or Irbesartan Each Combined with Hydrochlorothiazide in High-Risk Hypertensives Uncontrolled by Monotherapy: A Randomized, Double-Blind, Controlled, Parallel Group, Noninferiority Trial Zofenopril plus hydrochlorothiazide combination in the treatment of hypertension: an update.Efficacy of zofenopril in combination with thiazide diuretics in patients with acute myocardial infarction: a pooled individual data analysis of four randomized, double-blind, controlled, prospective studies.

P2860

Q30235416-FDD0D0CD-FCD6-41DC-ADA9-B6732E3AB307 Q33607150-9501E390-9016-4448-BD06-36CB3BB39B30 Q35968961-B8548953-EC56-446C-ADFB-FFED0B4888B0 Q38237435-3AAB3F29-CFA3-44BB-BA9F-FB73F19BF3AE Q55698458-06D8FBC0-81E9-4BFD-852F-9EE944E8C71A

P2860

Zofenopril plus hydrochlorothiazide and irbesartan plus hydrochlorothiazide in previously treated and uncontrolled diabetic and non-diabetic essential hypertensive patients

http://www.wikidata.org/entity/Q34397337

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Zofenopril plus hydrochlorothi ...... ssential hypertensive patients

@ast

Zofenopril plus hydrochlorothi ...... ssential hypertensive patients

@en

Zofenopril plus hydrochlorothi ...... ssential hypertensive patients

@nl

type

label

Zofenopril plus hydrochlorothi ...... ssential hypertensive patients

@ast

Zofenopril plus hydrochlorothi ...... ssential hypertensive patients

@en

Zofenopril plus hydrochlorothi ...... ssential hypertensive patients

@nl

prefLabel

Zofenopril plus hydrochlorothi ...... ssential hypertensive patients

@ast

Zofenopril plus hydrochlorothi ...... ssential hypertensive patients

@en

Zofenopril plus hydrochlorothi ...... ssential hypertensive patients

@nl

P1433

Q34397337-DB5A1B2F-9A0E-4B95-BCA9-C8057758B7B6

P1476

Q34397337-59E16FED-47E0-40F1-AF86-91546FE6E2CF

P2093

Q34397337-12373C82-76E8-4374-966D-4255F3F3364E

Q34397337-4574966B-AF7D-4328-BC58-D68F16A29A0E

Q34397337-F8CBEF07-77E3-40B6-91FE-DFB9B0D8EB45

Q34397337-FD2CC7BE-0CE7-462C-887D-F93EF3EE16DF

P2860

Q34397337-0205912B-B925-46EC-9E89-2676499C49B9

Q34397337-04260083-7BB5-4F46-B6CD-2F19C6CD4C9A

Q34397337-0A05DD46-EC87-4B54-86B5-D7F4D948FDA5

Q34397337-0E723675-33C1-4402-A96A-655002D32C90

Q34397337-1E3D714A-D104-4A1B-B442-EE704AD04860

Q34397337-22CC0A33-85B3-4406-AB30-6140C2AA04BC

Q34397337-25A35FCD-6EE2-4EE3-B2C7-86DFEB68E138

Q34397337-268B3AED-425B-42D7-801C-7CF4CCD56560

Q34397337-2AE55B93-0E79-4068-ABDC-D59F89FBE3A0

Q34397337-2BD3291B-9593-42A8-B493-6F383E44860E

P2888

Q34397337-6739E614-DEC0-437A-B2B4-C175CEA00185

P304

Q34397337-BE0DA270-264F-4DC5-B855-B8A5A2C5CC1D

P31

Q34397337-CA6B760A-E632-49B7-90A7-926A5F4E4E82

P356

Q34397337-8BECA0E7-6E60-48B3-AB0F-D22D97D982A7

P407

Q34397337-460AA5C7-66E9-4042-BC6D-A35084769657

P433

Q34397337-BA4A0262-6135-4D44-B871-3DF0B8951D85

P478

Q34397337-A77C8477-3864-426E-9BA0-A57C4797B346

P50

Q34397337-B78732EA-F69B-442F-B2A7-CA39DBC73567

P577

Q34397337-1041C3A2-E6ED-4915-9DD8-B12FBD7ABC5A

P5875

Q34397337-EDE9CF14-C219-448E-839B-80AE49C03B6A

P6179

Q34397337-AED847DA-370A-43B8-8477-1D6DE7321985

P698

Q34397337-06EF87C0-2464-4368-8CF0-4A7534E6F342

P921

Q34397337-49200A95-68E8-45C6-804B-79CACFDB38DE

P932

Q34397337-6A2DCD85-FD06-41A3-BF14-C01C001B0E08

P356

S12325-013-0090-8

P1433

Advances in Therapy

P1476

Zofenopril plus hydrochlorothi ...... ssential hypertensive patients

@en

P2093

Athanasios Manolis

http://www.w3.org/2001/XMLSchema#string

Dario Zava

http://www.w3.org/2001/XMLSchema#string

Enrico Agabiti-Rosei

http://www.w3.org/2001/XMLSchema#string

ZODIAC Study Group

http://www.w3.org/2001/XMLSchema#string

P2860

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Global burden of hypertension: analysis of worldwide data

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

An evaluation of the initial and long-term antihypertensive efficacy of zofenopril compared with enalapril in mild to moderate hypertension.

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

P2888

s12325-013-0090-8

P304

217-233

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12325-013-0090-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259700849

http://www.w3.org/2001/XMLSchema#string

P6179

1029036537

http://www.w3.org/2001/XMLSchema#string

P698

24415271

http://www.w3.org/2001/XMLSchema#string

P921

P932

3930838

http://www.w3.org/2001/XMLSchema#string